These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 19645131

  • 1. Molecular characteristics therapy in AML.
    Radich GP.
    Clin Adv Hematol Oncol; 2009 Jun; 7(6):11-4. PubMed ID: 19645131
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Incorporating novel treatment strategies into conventional therapy.
    Estey EH.
    Clin Adv Hematol Oncol; 2009 Jun; 7(6):4-7. PubMed ID: 19645129
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Emerging treatments in acute myeloid leukaemia.
    Kell J.
    Expert Opin Emerg Drugs; 2004 May; 9(1):55-71. PubMed ID: 15155136
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Strategies in the treatment of acute myeloid leukemia.
    Lowenberg B.
    Haematologica; 2004 Sep; 89(9):1029-32. PubMed ID: 15377460
    [No Abstract] [Full Text] [Related]

  • 9. Genetics in the management of adult de novo AML.
    Bloomfield CD.
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):640, 645-6. PubMed ID: 16258460
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Independent prognostic factors for AML outcome.
    Grimwade D, Hills RK.
    Hematology Am Soc Hematol Educ Program; 2009 Nov; ():385-95. PubMed ID: 20008224
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Acute myeloid leukemia: 2014 update on risk-stratification and management.
    Estey EH.
    Am J Hematol; 2014 Nov; 89(11):1063-81. PubMed ID: 25318680
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF, Fan ZP, Zhang Y, Jiang ZJ, Wang CY, Xu D, Sun J, Xiao Y, Tan H.
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.